Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells
Open Access
- 6 June 2011
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 130 (10), 2259-2270
- https://doi.org/10.1002/ijc.26228
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical ImplicationsEndocrine Reviews, 2007
- Poorly Differentiated Follicular Thyroid Carcinoma: Prognostic Factors and Relevance of Histological ClassificationThyroid®, 2007
- Gene Methylation in Thyroid TumorigenesisEndocrinology, 2007
- P53 abnormalities and outcomes in colorectal cancer: a systematic reviewBritish Journal of Cancer, 2005
- Targeting p53 by PTD-mediated transductionTrends in Biotechnology, 2004
- Descriptive Epidemiology of Thyroid Carcinoma in Carinthia, Austria: 1984–2001. Histopathologic Features and Tumor Classification of 734 Cases Under Elevated General Iodination of Table Salt Since 1990: Population-Based Age-Stratified Analysis on Thyroid Carcinoma IncidenceThyroid®, 2004
- P53 mutations in thyroid carcinoma: Tidings from an old foeJournal of Endocrinological Investigation, 2001
- Annual Report to the Nation on the Status of Cancer (1973 Through 1998), Featuring Cancers With Recent Increasing TrendsJNCI Journal of the National Cancer Institute, 2001
- Effects of p53-Expressing Adenovirus on the Chemosensitivity and Differentiation of Anaplastic Thyroid Cancer CellsJournal of Clinical Endocrinology & Metabolism, 1998
- High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.JCI Insight, 1993